» Articles » PMID: 39441322

ASO Author Reflections: Biological Contraindications to Surgery in Colorectal Liver Metastasis

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2024 Oct 23
PMID 39441322
Authors
Affiliations
Soon will be listed here.
References
1.
Fong Y, Fortner J, Sun R, Brennan M, Blumgart L . Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999; 230(3):309-18; discussion 318-21. PMC: 1420876. DOI: 10.1097/00000658-199909000-00004. View

2.
Nozawa H, Ito S, Sasaki K, Murono K, Emoto S, Yokoyama Y . Role of Adjuvant Chemotherapy After Surgical Resection of Paraaortic Lymph Node Metastasis from Colorectal Cancer-A Multicenter Retrospective Study. Ann Surg Oncol. 2024; 32(4):2282-2291. PMC: 11882702. DOI: 10.1245/s10434-024-16537-6. View

3.
Passot G, Denbo J, Yamashita S, Kopetz S, Chun Y, Maru D . Is hepatectomy justified for patients with RAS mutant colorectal liver metastases? An analysis of 524 patients undergoing curative liver resection. Surgery. 2016; 161(2):332-340. DOI: 10.1016/j.surg.2016.07.032. View

4.
Margonis G, Sasaki K, Gholami S, Kim Y, Andreatos N, Rezaee N . Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases. Br J Surg. 2018; 105(9):1210-1220. PMC: 7988484. DOI: 10.1002/bjs.10838. View

5.
Brudvik K, Jones R, Giuliante F, Shindoh J, Passot G, Chung M . RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases. Ann Surg. 2017; 269(1):120-126. DOI: 10.1097/SLA.0000000000002319. View